Literature DB >> 31982139

The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.

Sasithorn Wanna-Udom1, Minoru Terashima1, Hanbing Lyu1, Akihiko Ishimura1, Takahisa Takino2, Matomo Sakari3, Toshifumi Tsukahara3, Takeshi Suzuki4.   

Abstract

N6-Methyladenosine (m6A) is the most common internal chemical modification of mRNAs involved in many pathological processes including various cancers. In this study, we investigated the role of m6A methyltransferase METTL3 in TGF-β-induced epithelial-mesenchymal transition (EMT) of lung cancer cell lines. The expression of METTL3 and m6A RNA modification were increased during TGF-β-induced EMT of A549 and LC2/ad lung cancer cells. Knockdown of METTL3 inhibited TGF-β-induced morphological conversion of the cells, enhanced cell migration potential and the expression changes of EMT-related marker genes such as CDH1/E-cadherin, FN1/Fibronectin and VIM/Vimentin. Mechanistic investigations revealed that METTL3 knockdown decreased the m6A modification, total mRNA level and mRNA stability of JUNB, one of the important transcriptional regulators of EMT. Over-expression of JUNB partially rescued the inhibitory effects of METTL3 knockdown in the EMT phenotypes. This study demonstrates that m6A methyltransferase METTL3 is indispensable for TGF-β-induced EMT of lung cancer cells through the regulation of JUNB.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epithelial-mesenchymal transition; JUNB; Lung cancer; METTL3; RNA methylation

Year:  2020        PMID: 31982139     DOI: 10.1016/j.bbrc.2020.01.042

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  46 in total

Review 1.  RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy.

Authors:  Subhadra Kumari; Santosh Kumar; Srinivasan Muthuswamy
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-07       Impact factor: 4.553

2.  m6A-express: uncovering complex and condition-specific m6A regulation of gene expression.

Authors:  Teng Zhang; Shao-Wu Zhang; Song-Yao Zhang; Shou-Jiang Gao; Yidong Chen; Yufei Huang
Journal:  Nucleic Acids Res       Date:  2021-11-18       Impact factor: 16.971

3.  Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.

Authors:  Shengshu Li; Xiaoxin Lu; Dongyang Zheng; Weizong Chen; Yuzhu Li; Fang Li
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-30       Impact factor: 4.322

4.  Wilms tumor 1 associated protein promotes epithelial mesenchymal transition of gastric cancer cells by accelerating TGF-β and enhances chemoradiotherapy resistance.

Authors:  Yu Liu; Mingxu Da
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-28       Impact factor: 4.322

Review 5.  Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application.

Authors:  Fusheng Zhang; Haiyang Liu; Meiqi Duan; Guang Wang; Zhenghou Zhang; Yutian Wang; Yiping Qian; Zhi Yang; Xiaofeng Jiang
Journal:  J Hematol Oncol       Date:  2022-07-06       Impact factor: 23.168

Review 6.  Multiple roles of m6A methylation in epithelial-mesenchymal transition.

Authors:  Xueru Zhao; Xue Li; Xiaohua Li
Journal:  Mol Biol Rep       Date:  2022-03-20       Impact factor: 2.742

Review 7.  Advances in the functional roles of N6-methyladenosine modification in cancer progression: mechanisms and clinical implications.

Authors:  Peilin Chen; Jianhang Hu; Xiaodong Han; Yabing Chen
Journal:  Mol Biol Rep       Date:  2022-01-13       Impact factor: 2.742

8.  Involvement of METTL3/m6Adenosine and TGFβ/Smad3 signaling on Tenon's fibroblasts and in a rabbit model of glaucoma surgery.

Authors:  Yan Liu; Chao Gu; Xiabin Li; Tingwei Wang; Ling Yu
Journal:  J Mol Histol       Date:  2021-11-02       Impact factor: 2.611

9.  m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma.

Authors:  Jianhao Li; Weiwei Wang; Yubing Zhou; Liwen Liu; Guizhen Zhang; Kelei Guan; Xichun Cui; Xin Liu; Maoxin Huang; Guangying Cui; Ranran Sun
Journal:  Front Cell Dev Biol       Date:  2021-07-02

10.  METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.

Authors:  Yongxi Zhang; Shuyuan Liu; Tiesuo Zhao; Chengxue Dang
Journal:  Oncol Rep       Date:  2021-06-16       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.